Orthofix Medical Inc.
Orthofix Medical Inc. (OFIX) Financial Performance & Income Statement Overview
Review Orthofix Medical Inc. (OFIX) income statement, balance sheet, and cash flow reports with annual and quarterly breakdowns.
Orthofix Medical Inc. (OFIX) Income Statement & Financial Overview
View the income breakdown for Orthofix Medical Inc. OFIX across both annual and quarterly reports.
| Metric | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 |
|---|---|---|---|---|
| Revenue | $203.12M | $193.65M | $215.66M | $196.61M |
| Cost of Revenue | $63.59M | $72.03M | $58.27M | $61.55M |
| Gross Profit | $139.53M | $121.62M | $157.38M | $135.05M |
| Gross Profit Ratio | $0.69 | $0.63 | $0.73 | $0.69 |
| R&D Expenses | $15.93M | $19.77M | $18.81M | $17.29M |
| SG&A Expenses | $136.49M | $132.98M | $136.48M | $130.14M |
| Operating Expenses | $152.43M | $170.49M | $163.37M | $153.95M |
| Total Costs & Expenses | $216.01M | $242.52M | $227.13M | $215.50M |
| Interest Income | $0.00 | $0.00 | $0.00 | $0.00 |
| Interest Expense | -$3.95M | $4.51M | $14.92M | $5.21M |
| Depreciation & Amortization | $0.00 | $35.68M | $27.33M | $16.79M |
| EBITDA | -$12.89M | -$11.95M | $12.54M | -$4.64M |
| EBITDA Ratio | -$0.06 | -$0.06 | $0.06 | -$0.02 |
| Operating Income | -$12.89M | -$48.87M | -$11.48M | -$18.90M |
| Operating Income Ratio | -$0.06 | -$0.25 | -$0.05 | -$0.10 |
| Other Income/Expenses (Net) | -$1.33M | -$3.26M | -$18.23M | -$7.74M |
| Income Before Tax | -$14.22M | -$52.13M | -$29.71M | -$26.64M |
| Income Before Tax Ratio | -$0.07 | -$0.27 | -$0.14 | -$0.14 |
| Income Tax Expense | $142000.00 | $961000.00 | -$564000.00 | $751000.00 |
| Net Income | -$14.08M | -$53.09M | -$29.15M | -$27.39M |
| Net Income Ratio | -$0.07 | -$0.27 | -$0.14 | -$0.14 |
| EPS | -$0.36 | -$1.35 | -$0.75 | -$0.71 |
| Diluted EPS | -$0.36 | -$1.35 | -$0.75 | -$0.71 |
| Weighted Avg Shares Outstanding | $39.50M | $39.19M | $38.70M | $38.49M |
| Weighted Avg Shares Outstanding (Diluted) | $39.50M | $39.19M | $38.70M | $38.49M |
Over the past four quarters, Orthofix Medical Inc. demonstrated steady revenue growth, increasing from $196.61M in Q3 2024 to $203.12M in Q2 2025. Operating income reached -$12.89M in Q2 2025, maintaining a consistent -6% margin over recent quarters. Despite fluctuations in R&D and SG&A expenses, EBITDA remained robust at -$12.89M, reflecting operational efficiency. Net income rose to -$14.08M, with EPS at -$0.36. Disciplined expense management helped sustain profitability, highlighting solid overall financial performance.
Unlock 25+ Years of Financial Data
Get access to extended historical data, advanced metrics, and more with our premium plan